Rhythm Biosciences (ASX:RHY) raises $2.5M in rights issue to advance cancer diagnostics

Grafa03-21

Rhythm Biosciences, an Australian firm specialising in predictive cancer diagnostics, closed its rights issue, raising $2.5 million. The effort aligns with the company's commitment to advancing cancer...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2421766033?lang=en_US&edition=fundamental","thumbnail":"https://images.grafa.com/grafa/media-198581-638465821805769032.jpg","is_english":true,"pubTime":"2024-03-21 09:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2421766033","market":null,"top_or_hot":-1,"title":"Rhythm Biosciences (ASX:RHY) raises $2.5M in rights issue to advance cancer diagnostics","media":"Grafa","content":"<div>\n<p>Rhythm Biosciences, an Australian firm specialising in predictive cancer diagnostics, closed its rights issue, raising $2.5 million.\nThe effort aligns with the company's commitment to advancing cancer...</p>\n\n<a href=\"https://grafa.com/news/rhythm-biosciences--asx-rhy--raises--2-5m-in-rights-issue-to-advance-cancer-diagnostics-198581?referralcode=A314DFDBE96C354756A893C6E3E02493\">Source Link</a>\n\n</div>\n","source":"grafa_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rhythm Biosciences (ASX:RHY) raises $2.5M in rights issue to advance cancer diagnostics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRhythm Biosciences (ASX:RHY) raises $2.5M in rights issue to advance cancer diagnostics\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-21 09:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://grafa.com/news/rhythm-biosciences--asx-rhy--raises--2-5m-in-rights-issue-to-advance-cancer-diagnostics-198581?referralcode=A314DFDBE96C354756A893C6E3E02493><strong>Grafa</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Rhythm Biosciences, an Australian firm specialising in predictive cancer diagnostics, closed its rights issue, raising $2.5 million.\nThe effort aligns with the company's commitment to advancing cancer...</p>\n\n<a href=\"https://grafa.com/news/rhythm-biosciences--asx-rhy--raises--2-5m-in-rights-issue-to-advance-cancer-diagnostics-198581?referralcode=A314DFDBE96C354756A893C6E3E02493\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7124","symbol_name":"保健护理服务","start_time":0,"source_url":"https://grafa.com/news/rhythm-biosciences--asx-rhy--raises--2-5m-in-rights-issue-to-advance-cancer-diagnostics-198581?referralcode=A314DFDBE96C354756A893C6E3E02493","article_id":"2421766033","we_media_id":null,"thumbnails":["https://images.grafa.com/grafa/media-198581-638465821805769032.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2421766033","pubTimestamp":1710985384,"sourceInfo":{"source_id":"grafa_news","name":"Grafa"},"weMediaInfo":null,"summary":"Rhythm Biosciences, an Australian firm specialising in predictive cancer diagnostics, closed its rights issue, raising $2.5 million.The effort aligns with the company's commitment to advancing cancer detection through innovative blood tests.The remaining shortfall shares are placed with an open commitment book for interest registration.Shares and options were allotted on March 21, with new share trading beginning on March 22.","collect":0,"end_time":0,"defaultTopTitle":"grafa.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7124":"保健护理服务","RHY.AU":"RHYTHM BIOSCIENCES LTD"},"translate_title":"Rhythm Biosciences（ASX：RHY）通过配股筹集250万美元，推进癌症诊断","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHY.AU":1},"content_text":"Rhythm Biosciences, an Australian firm specialising in predictive cancer diagnostics, closed its rights issue, raising $2.5 million.\nThe effort aligns with the company's commitment to advancing cancer detection through innovative blood tests.\nThe remaining shortfall shares are placed with an open commitment book for interest registration.\nShares and options were allotted on March 21, with new share trading beginning on March 22.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2421766033"}